Korea Green Cross, and Jaseng oriental hospital to jointly develop natural new drugs

Published: 2003-12-15 06:57:00

Updated: 2003-12-15 06:57:00

Korea Green Cross R&D Co., an affiliated company of Korea Green Cross Corporation said that it signed with Jaseng oriental hospital a strategic joint venture in the development of natural new drugs on December 10.

KGC R&D plans to invest a total of 10 billion won for the next five years to commercialize shinbarometin, a potential drug for the prevention and treatment of osteoporosis, which w...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.